| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Marksans Pharma Limited (NSE: MARKSANS)
MARKSANS Technical Analysis
5
| As on 19th Apr 2024 MARKSANS SHARE Price closed @ 174.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 126.41 & Strong Buy for SHORT-TERM with Stoploss of 154.51 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MARKSANSSHARE Price
| Open | 167.40 | Change | Price | % |
| High | 178.65 | 1 Day | 3.85 | 2.26 |
| Low | 165.25 | 1 Week | 11.45 | 7.03 |
| Close | 174.30 | 1 Month | 32.70 | 23.09 |
| Volume | 4856047 | 1 Year | 96.95 | 125.34 |
| 52 Week High 118.95 | 52 Week Low 39.45 | ||||
NSE INDIA Most Active Stocks
| IDEA | 12.90 | -2.27% |
| YESBANK | 23.95 | 0.21% |
| GTLINFRA | 1.75 | 0.00% |
| NHPC | 87.15 | -2.63% |
| TATASTEEL | 162.10 | 1.28% |
| SUZLON | 39.35 | -4.37% |
| INDUSTOWER | 351.40 | 2.03% |
| PNB | 128.25 | -1.00% |
| SAIL | 146.05 | 0.86% |
| ZOMATO | 189.20 | 2.16% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| EXCEL | 0.50 | -9.09% |
| ANMOL | 42.25 | -7.85% |
| SHARDAMOTR | 1504.15 | -5.41% |
| TATACOMM | 1755.20 | -5.33% |
| JUBLPHARMA | 665.00 | -5.09% |
| ARENTERP | 52.10 | -5.01% |
| PVP | 31.30 | -5.01% |
| PVP | 31.30 | -5.01% |
| ARVEE | 237.35 | -5.00% |
| GKWLIMITED | 2531.05 | -5.00% |
| MARKSANS Daily Charts |
MARKSANS Intraday Charts |
Whats New @ Bazaartrend |
MARKSANS Free Analysis |
|
|
MARKSANS Important Levels Intraday
| RESISTANCE | 200.12 |
| RESISTANCE | 191.84 |
| RESISTANCE | 186.72 |
| RESISTANCE | 181.60 |
| SUPPORT | 167.00 |
| SUPPORT | 161.88 |
| SUPPORT | 156.76 |
| SUPPORT | 148.48 |
MARKSANS Target April 2024
| 4th UP Target | 218.84 |
| 3rd UP Target | 198.85 |
| 2nd UP Target | 186.49 |
| 1st UP Target | 174.13 |
| 1st DOWN Target | 138.87 |
| 2nd DOWN Target | 126.51 |
| 3rd DOWN Target | 114.15 |
| 4th DOWN Target | 94.16 |
MARKSANS Weekly Target
| 4th UP Target | 183.37 |
| 3rd UP Target | 176.79 |
| 2nd UP Target | 172.72 |
| 1st UP Target | 168.65 |
| 1st DOWN Target | 157.05 |
| 2nd DOWN Target | 152.98 |
| 3rd DOWN Target | 148.91 |
| 4th DOWN Target | 142.33 |
MARKSANS Target2024
| 4th UP Target | 405.06 |
| 3rd UP Target | 326.82 |
| 2nd UP Target | 278.46 |
| 1st UP Target | 230.1 |
| 1st DOWN Target | 92.1 |
| 2nd DOWN Target | 43.74 |
| 3rd DOWN Target | -4.62 |
| 4th DOWN Target | -82.86 |
Marksans Pharma Limited ( NSE INDIA Symbol : MARKSANS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MARKSANS Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -77.01 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 13.90 | |
| 10 Day Avg Volume | Traded -20.95 % Less then 10 Day Average Volume | ||
MARKSANS Other Details
| Segment | EQ | |
| Market Capital | 27935678464.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-General | |
| Offical website | > | |
MARKSANS Address
 |
||
MARKSANS Latest News
MARKSANS Business Profile
Marksans Pharma Limited, together with its subsidiaries, engages in the research and , development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations in North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the analgesic, anti-inflammatory, benign prostatic hyperplasia, epilepsy, hyperparathyroidism, diabetic and antidiabetic, pain management, neurology, hormonal, antifungal, antiulcerative, cardiovascular and central nervous system, vitamin, cough and cold, dermatology, gastrointestinal, cephalosporin, injectable, antibacterial, hypertension, oncology, and antibiotics and anti-allergic therapeutic areas. It also provides contract research and manufacturing services, as well as distributes generic pharma products. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India. Address: Grandeur, Mumbai, India, 400053
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service